10.30.20
8 min. Read

18 digital health SPACs.

Issue 076

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about how this newsletter will change starting next month (which is next week!). I also dug back into pricing strategies for DTx and shared a few thoughts on the rise of CGMs for wellness.

Earlier this week I sent out the first version of the new (free) funding newsletter, E&O

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.
11.07.25
6 min. Read
Pricing for Sword Health, Hinge Health, Joint Academy in the UK.
10.31.25
7 min. Read
Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.
10.24.25
7 min. Read
Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.
10.17.25
5 min. Read
Revisiting E&O scoops, pricing intel, revenue finds
10.10.25
7 min. Read
Big Health’s 2024 revenue shrinks. 2025: Runway worries.
9.26.25
5 min. Read
Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.
9.18.25
7 min. Read
Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.
9.12.25
4 min. Read
Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.
9.05.25
6 min. Read
Pricing updates: Teladoc, Maven, Garner, Kaia and more
8.29.25
4 min. Read
  • First
  • Previous
  • 1 of 41
  • Next
  • Last